Biofourmis Raises $35M to Advance AI Drug Software, Plans Move to Boston

Biofourmis Raises $35M to Advance AI Drug Software, Plans Move to Boston »

21 May, 2019
CompaniesNews
  Digital therapeutics company Biofourmis announced today that it will be moving its headquarters from Singapore to Boston following the closing of a $35 million Series B financing round. Biofourmis said that the move to Boston will help the company advance its proprietary artificial intelligence (AI)-powered digital therapeutics platform and pipeline, which are designed to…

Send this to a friend